Radiotherpy in Breast Cancer. Malignant neoplasm of breast
Conditions
Interventions
Intervention 1: Intervention group: daily concurrent RT boost. In the concomitant boost group, a total dose of 8 grey will be treated with 50 c-grey daily with basic radiotherapy. Intervention 2: Inte
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Female Older than 18 Stage 1 or 2 Breast conservating surgery Negative margin Negative lymph node
Exclusion criteria
Exclusion criteria: positive LN at axillary dissection Multifocal tumour Paget’s disease pathological skin involvement, synchronous or previous breast cancer, other malignant disease, pregnant or lactating patient Previous irradiation to ipsilateral breast or thorax
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin Reactin. Timepoint: After Radiotherapy, 1 month later, every 3 months up to 1 year. Method of measurement: Use NCI CTCAE version 3.0 toxicity criteria and rates of acute toxicity. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cosmetic result. Timepoint: 3 months. Method of measurement: Comparison with healthy opposite breasts in size, indentation, shape and symmetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNaeim Nabian
Tehran University of Medical Sciences
Outcome results
None listed